Preserved striatal innervation maintains motor function despite severe loss of nigral dopaminergic neurons.

Autor: Paß T; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany., Ricke KM; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany., Hofmann P; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany., Chowdhury RS; MRC Mitochondrial Biology Unit, University of Cambridge, CB2 0XY Cambridge, UK., Nie Y; MRC Mitochondrial Biology Unit, University of Cambridge, CB2 0XY Cambridge, UK., Chinnery P; MRC Mitochondrial Biology Unit, University of Cambridge, CB2 0XY Cambridge, UK., Endepols H; Faculty of Medicine and University Hospital Cologne, University of Cologne, Institute of Radiochemistry and Experimental Molecular Imaging, 50937 Cologne, Germany.; Department of Nuclear Medicine, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany., Neumaier B; Faculty of Medicine and University Hospital Cologne, University of Cologne, Institute of Radiochemistry and Experimental Molecular Imaging, 50937 Cologne, Germany.; Forschungszentrum Jülich GmbH, Institute of Neuroscience and Medicine, Nuclear Chemistry (INM-5), 52425 Jülich, Germany.; Max Planck Institute for Metabolism Research, 50931 Cologne, Germany., Carvalho A; Max Planck Institute for Metabolism Research, 50931 Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD) and Centre for Molecular Medicine (CMMC), University of Cologne, 50931 Cologne, Germany., Rigoux L; Max Planck Institute for Metabolism Research, 50931 Cologne, Germany., Steculorum SM; Max Planck Institute for Metabolism Research, 50931 Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD) and Centre for Molecular Medicine (CMMC), University of Cologne, 50931 Cologne, Germany., Prudent J; MRC Mitochondrial Biology Unit, University of Cambridge, CB2 0XY Cambridge, UK., Riemer T; Department of Paediatrics and Adolescent Medicine, Experimental Neonatology, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany., Aswendt M; Department of Neurology, University of Cologne, Faculty of Medicine and University Hospital Cologne, 50937 Cologne, Germany., Liss B; Institute of Applied Physiology, University of Ulm, 89081 Ulm, Germany., Brachvogel B; Department of Paediatrics and Adolescent Medicine, Experimental Neonatology, Faculty of Medicine, University of Cologne, 50937 Cologne, Germany., Wiesner RJ; Center for Physiology and Pathophysiology, Institute of Vegetative Physiology, Faculty of Medicine and University Hospital Cologne, 50931 Cologne, Germany.; Cologne Excellence Cluster on Cellular Stress Responses in Aging-associated Diseases (CECAD) and Centre for Molecular Medicine (CMMC), University of Cologne, 50931 Cologne, Germany.

Publikováno v: Brain : a journal of neurology [Brain] 2024 Sep 03; Vol. 147 (9), pp. 3189-3203.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of Access Site on Periprocedural Bleeding and Cerebral and Coronary Events in High-Bleeding-Risk Percutaneous Coronary Intervention: Findings from the RIVA-PCI Trial.

Autor: Borlich M; Herz- und Gefäßzentrum, Segeberger Kliniken GmbH, Am Kurpark 1, Bad Segeberg, Schleswig-Holstein, 23795, Bad Segeberg, Germany. martin.borlich@segebergerkliniken.de., Zeymer U; Medizinische Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany.; Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany., Wienbergen H; Klinikum Links der Weser Bremen, Bremen, Germany., Hobbach HP; Kreisklinikum Siegen, Siegen, Germany., Cuneo A; Krankenhaus und MVZ Maria-Hilf Stadtlohn, Stadtlohn, Germany., Bekeredjian R; Robert-Bosch-Klinikum, Stuttgart, Germany., Ritter O; Klinikum Brandenburg Havel, Brandenburg, Germany., Hailer B; Katholische Kliniken Essen-Nord-West gGmbH, Essen, Germany., Hertting K; Krankenhaus Buchholz und Winsen GmbH, Buchholz, Germany., Hennersdorf M; SLK-Kliniken Heilbronn GmbH, Heilbronn, Germany., Scholtz W; Herz-und Diabeteszentrum, Bad Oeynhausen, Germany., Lanzer P; Gesundheitszentrum Bitterfeld Wolfen, Bitterfeld, Germany., Mudra H; Städtisches Krankenhaus Neuperlach-München, Munich, Germany., Schwefer M; Elblandklinikum Riesa, Riesa, Germany., Schwimmbeck PL; Klinikum Leverkusen, Leverkusen, Germany., Liebetrau C; Kerckhoff-Klinik GmbH, Bad Nauheim, Germany., Thiele H; Herzzentrum Leipzig der Universität Leipzig, Leipzig, Germany., Claas C; Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany., Riemer T; Institut für Herzinfarktforschung Ludwigshafen, Ludwigshafen, Germany., Zahn R; Medizinische Klinik B, Klinikum Ludwigshafen, Ludwigshafen, Germany., Iden L; Herz- und Gefäßzentrum, Segeberger Kliniken GmbH, Am Kurpark 1, Bad Segeberg, Schleswig-Holstein, 23795, Bad Segeberg, Germany., Richardt G; Herz- und Gefäßzentrum, Segeberger Kliniken GmbH, Am Kurpark 1, Bad Segeberg, Schleswig-Holstein, 23795, Bad Segeberg, Germany., Toelg R; Herz- und Gefäßzentrum, Segeberger Kliniken GmbH, Am Kurpark 1, Bad Segeberg, Schleswig-Holstein, 23795, Bad Segeberg, Germany.; Medizinische Fakultät der Christian-Albrechts-Universität zu Kiel, Kiel, Germany.

Publikováno v: Cardiology and therapy [Cardiol Ther] 2024 Mar; Vol. 13 (1), pp. 89-101. Date of Electronic Publication: 2023 Dec 06.

Behandlung der neovaskulären altersbedingten Makuladegeneration: Erkenntnisse aus dem Berliner Makularegister über den Medikamentwechsel

Autor: Knecht, Vitus A., Riemer, T., Berndt, D., Böker, A., Urban, J., Schrifl, U., Rau, S., Rübsam, A., Joussen, A. M., Zeitz, O.

Publikováno v: 34. Jahrestagung der Retinologischen Gesellschaft; 20220701-20220702; Lübeck; DOC06.07 /20220629/

Hintergrund: Bevacizumab, Ranibizumab und Aflibercept werden zur Behandlung der neovaskulären altersbedingten Makuladegeneration (nAMD) eingesetzt. Die Studiendaten weisen auf keine statistische Unterlegenheit aller Medikamente hin, und die Medikame

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dcd9712d003040bc7e7cec9e118880b
http://nbn-resolving.de/urn:nbn:de:0183-22rg268

Correction to: Treatment of neovascular age-related macular degeneration: insights into drug-switch real-world from the Berlin Macular Registry.

Autor: Riemer T; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Berndt D; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Böker A; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Lehmann J; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Schrifl U; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Rau S; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Rübsam A; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Joussen AM; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Zeitz O; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany. oliver.zeitz@charite.de.

Publikováno v: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2023 Jun; Vol. 261 (6), pp. 1769.